Pediatric Autoimmune Pancreatitis: A Case of Obstructive Jaundice

Introduction Autoimmune pancreatitis (AIP) is a rare, distinct form of chronic pancreatitis [1], categorized into Type 1, often associated with elevated IgG4, and Type 2, which is less related to IgG4 and involves more localized ductal changes. In pediatric cases, AIP often lacks elevated IgG4, making diagnosis dependent on imaging findings and response to steroid therapy [2]. Case Presentation An 11-year-old boy presented with a one-month history of weight loss and fatigue, along with a few days of jaundice, pruritus, epigastric pain and dark urine. Laboratory results showed significantly elevated liver and pancreatic enzymes, with normal IgG and IgG4 levels. Imaging demonstrated biliary dilation, pancreatic head enlargement and main pancreatic duct compression. Ultrasound and MRI findings were consistent with AIP, with a suspected diagnosis of pancreas divisum (PD) and annular pancreas (AP). AP was further suspected during Endoscopic Retrograde Cholangiopancreatography (ERCP). Type 2 AIP was diagnosed based on clinical features, elevated enzymes, imaging and a positive response to corticosteroid therapy [3]. Treatment with prednisolone (1 mg/kg/day) and pancreatic enzyme supplementation led to symptom resolution and improved laboratory markers. Discussion Type 2 AIP is rare in children but should be considered in obstructive jaundice cases. In pediatric AIP, elevated IgG4 levels are often absent, diagnosis relies on imaging findings, elevated pancreatic and liver enzymes and positive response to corticosteroids [3]. Anatomical anomalies like PD (4% prevalence) and AP (0.01% prevalence) can impair drainage and contribute to inflammation [4,5]. These anomalies may coexist with AIP, mimic its features or be mistakenly diagnosed as AIP has similar symptoms. Since steroid therapy leads to rapid improvement, AIP is likely the primary condition, with anatomical anomalies either coexisting or being misdiagnosed initially. Conclusions This case highlights the significance of diagnosing AIP in pediatric patients presenting with obstructive jaundice. Early detection followed by swift steroid treatment resulted in notable clinical improvement, emphasizing the necessity of prompt intervention. Further research is needed to better understand the pathophysiology and longterm outcomes of pediatric AIP.

Authors

Publication Details

Journal
Lithuanian University of Health Sciences
Published
2025-03-13
Primary Topic
IgG4-Related and Inflammatory Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pediatric Autoimmune Pancreatitis: A Case of Obstructive Jaundice

Paulina Judzinskytė, Rūta Petrikėnė, Monika Zieniūtė
Lithuanian University of Health Sciences
IgG4-Related and Inflammatory Diseases
article

Pediatric Autoimmune Pancreatitis: A Case of Obstructive Jaundice

Paulina Judzinskytė, Rūta Petrikėnė, Monika Zieniūtė
article en

Abstract

Introduction Autoimmune pancreatitis (AIP) is a rare, distinct form of chronic pancreatitis [1], categorized into Type 1, often associated with elevated IgG4, and Type 2, which is less related to IgG4 and involves more localized ductal changes. In pediatric cases, AIP often lacks elevated IgG4, making diagnosis dependent on imaging findings and response to steroid therapy [2]. Case Presentation An 11-year-old boy presented with a one-month history of weight loss and fatigue, along with a few days of jaundice, pruritus, epigastric pain and dark urine. Laboratory results showed significantly elevated liver and pancreatic enzymes, with normal IgG and IgG4 levels. Imaging demonstrated biliary dilation, pancreatic head enlargement and main pancreatic duct compression. Ultrasound and MRI findings were consistent with AIP, with a suspected diagnosis of pancreas divisum (PD) and annular pancreas (AP). AP was further suspected during Endoscopic Retrograde Cholangiopancreatography (ERCP). Type 2 AIP was diagnosed based on clinical features, elevated enzymes, imaging and a positive response to corticosteroid therapy [3]. Treatment with prednisolone (1 mg/kg/day) and pancreatic enzyme supplementation led to symptom resolution and improved laboratory markers. Discussion Type 2 AIP is rare in children but should be considered in obstructive jaundice cases. In pediatric AIP, elevated IgG4 levels are often absent, diagnosis relies on imaging findings, elevated pancreatic and liver enzymes and positive response to corticosteroids [3]. Anatomical anomalies like PD (4% prevalence) and AP (0.01% prevalence) can impair drainage and contribute to inflammation [4,5]. These anomalies may coexist with AIP, mimic its features or be mistakenly diagnosed as AIP has similar symptoms. Since steroid therapy leads to rapid improvement, AIP is likely the primary condition, with anatomical anomalies either coexisting or being misdiagnosed initially. Conclusions This case highlights the significance of diagnosing AIP in pediatric patients presenting with obstructive jaundice. Early detection followed by swift steroid treatment resulted in notable clinical improvement, emphasizing the necessity of prompt intervention. Further research is needed to better understand the pathophysiology and longterm outcomes of pediatric AIP.

Lithuanian University of Health Sciences
Good health and well-being
Openalex Percentile: Top 22%
IgG4-Related and Inflammatory Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pediatric Autoimmune Pancreatitis: A Case of Obstructive Jaundice — Paulina Judzinskytė, Rūta Petrikėnė, et al. · Lithuanian University of Health Sciences (2025) | TGRS Research Map | TGRS